Fajardo, Cherry Mae T.

HRN: 19-16-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/08/2025
IV
2g
OD
For OR
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: